Journals

KOLLAREDDY, M., D. ZHELEVA, P. DŽUBÁK, P. BRAHMKSHATRIYA, M. LEPSIK, M. HAJDÚCH
Aurora kinase inhibitors: Progress towards the clinic. Investigational New Drugs. 2012, 30(6), 2411-2432, ISSN: 0167-6997, PMID: 22350019,
DŽUBÁK, P., S. GURSKÁ, K. BOGDANOVÁ, D. UHRIKOVA, N. KANJAKOVA, S. COMBET, T. KLUNDA, M. KOLÁŘ, M. HAJDÚCH, M. POLÁKOVÁ
Antimicrobial and cytotoxic activity of (thio)alkyl hexopyranosides, nonionic glycolipid mimetics. Carbohydrate Research. 2020, 488, 107905, ISSN: 0008-6215, PMID: 32004953,
VOLLER, J., L. ZAHAJSKA, L. PLÍHALOVÁ, J. JERABKOVA, D. BURGET, A. PATAKI, V. KRYŠTOF, M. ZATLOUKAL, J. BRABEK, D. ROSEL, V. MIK, M. TKAC, T. POSPÍŠIL, T. GUCKÝ, K. DOLEZAL, M. STRNAD
6-Substituted purines as ROCK inhibitors with anti-metastatic activity. Bioorganic Chemistry. 2019, 90, 103005, ISSN: 0045-2068, PMID: 31271944,
MADZHIDOV, T., A. RAKHIMBEKOVA, A. KUTLUSHINA, P. POLISHCHUK
Probabilistic Approach for Virtual Screening Based on Multiple Pharmacophores. Molecules. 2020, 25(2), pii: E385, ISSN: 1420-3049, PMID: 31963467,  PDF.
KRALOVA, V., M. SOURAL, R. HORÁK, P. HRADIL
Convenient Synthesis of Furo[3,2-b ]quinolin-4(1 H )-ones. Synlett. 2020, 31(9), 911-915, ISSN: 0936-5214,
OLIVERIUS, M., D. FLAŠAROVÁ, B. MOHELNÍKOVÁ DUCHOŇOVÁ, M. EHRLICHOVA, V. HLAVAC, O. STROUHAL, P. DVORAK, I. OJIMA, P. SOUCEK
KRAS pathway expression changes in pancreatic cancer models by conventional and experimental taxanes. Mutagenesis. 2019, 34(5-6), 403-411, ISSN: 0267-8357, PMID: 31375828,
BALIK, V., S. TAKEBAYASHI, K. TAKIZAWA
A Case Series of Double Bypass Technique Used for the Treatment of Internal Carotid Blood Blister-like Aneurysms in Patients in Poor Initial Neurological Condition at the Early Stage of Subarachnoid Hemorrhage. Operative Neurosurgery (Hagerstown, Md.). 2019, 18(2), 126-135, ISSN: 2332-4252, PMID: 31232429,
ČÍŽKOVÁ, K., P. FLODROVÁ, R. BARANOVA, J. MALOHLAVA, M. LACEY, Z. TAUBER
Beneficial Effect of Heat-induced Antigen Retrieval in Immunocytochemical Detection of Intracellular Antigens in Alcohol-fixed Cell Samples. Applied Immunohistochemistry and Molecular Morphology. 2020, 28(2), 166-174, ISSN: 1541-2016, PMID: 32044886,
DIETLEIN, F., B. KALB, M. JOKIC, E. NOLL, A. STRONG, L. THARUN, L. OZRETIC, H. KUNSTLINGER, K. KAMBARTEL, W. RANDERATH, C. JUNGST, A. SCHMITT, A. TORGOVNICK, A. RICHTERS, D. RAUH, F. SIEDEK, T. PERSIGEHL, C. MAUCH, J. BARTKOVA, A. BRADLEY, M. SPRICK, A. TRUMPP, R. RAD, D. SAUR, J. BÁRTEK, J. WOLF, R. BUTTNER, R. THOMAS, H. REINHARDT
A Synergistic Interaction between Chk1-and MK2 Inhibitors in KRAS-Mutant Cancer. Cell. 2015, 162(1), 146-159, ISSN: 0092-8674, PMID: 26140595,  PDF.
GACHECHILADZE, M., T. TICHÝ, V. KOLEK, I. GRYGÁRKOVÁ, J. KLEIN, G. MGEBRISHVILI, G. KHARAISHVILI, M. JANÍKOVÁ, P. SMICKOVA, L. CIERNA, S. PITSON, M. MADDELEIN, O. CUVILLIER, J. ŠKARDA
Sphingosine kinase-1 predicts overall survival outcomes in non-small cell lung cancer patients treated with carboplatin and navelbine. Oncology Letters. 2019, 18(2), 1259-1266, ISSN: 1792-1074, PMID: 31423186,